Gliapharm SA

Gliapharm SA, public limited company in Genève (GE), research. Registration active in the commercial register since 2017. Latest publication: May 19, 2025. UID CHE-193.477.382.

GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. It is discovering and developing medicines that target glia-mediated pathways for neuroprotection and maintenance of cognitive functions.¹

Commercial register

Legal form: Public limited company
Registered office: chemin des Mines 9, 1202 Genève
Share capital: CHF 100,000
UID: CHE-193.477.382
Registered since: 2017
Registered purpose (original language): la Société a pour but la recherche, le développement et la commercialisation de substances pharmaceutiques visant à traiter les maladies neurologiques (pour but complet cf. statuts). Show moreShow less

All 25 companies registered at this address

Similar companies

Neurosterix SA Genève Manufacture of basic pharmaceutical products
Neurosterix Pharma Sàrl Genève Manufacture of basic pharmaceutical products
Kyowa Kirin Sàrl Genève Wholesale trade
TRBH International SA Plan-les-Ouates Retail trade
TRB CHEMEDICA INTERNATIONAL SA Carouge (GE) Wholesale trade
Oculis Operations Sàrl Lausanne Manufacture of basic pharmaceutical products

A free account opens every company that looks like Gliapharm SA, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Officers changed May 19, 2025

Gliapharm SA, à Genève, CHE-193.477.382 (FOSC du 05.08.2022, p. 0/1005536180). Augmentation du capital-participation au moyen d'un capital conditionnel, fondée sur la clause statutaire du 26.07.2016 relative à une augmentation du capital-participation au moyen d'un capital conditionnel, par l'émission de 10'000 bons de participation de CHF 1, nominatifs, liés selon statuts. Capital-participation: CHF 16'200, entièrement libéré, divisé en 16'200 bons de CHF 1, nominatifs, liés selon statuts. Statuts modifiés le 30.04.2025. Lengacher Sylvain, administrateur, n'est plus président. Bushara Leon, des Etats-Unis, à Commonwealth, USA, est nommé membre président du conseil d'administration avec signature collective à deux.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.